...
【24h】

Multifocal motor neuropathy

机译:多灶性运动神经病

获取原文
获取原文并翻译 | 示例
           

摘要

Multifocal motor neuropathy (MMN) was first described in 1988 as a purely motor neuropathy affecting multiple motor nerves. The diagnosis was based entirely on demonstrating electrophysiological evidence of a conduction block (CB) that selectively affected motor axons, with sparing of sensory axons even through the site of motor CB. Subsequently, a similar disorder was reported but with absence of demonstrable CB on routine nerve conduction studies and there is still some debate as to whether MMN without CB is related to MMN. MMN is thought to be an inflammatory neuropathy related to an immune attack on motor nerves. The conventional hypothesis is that the primary pathology is segmental demyelination, but recent research raises the possibility of a primary axonopathy. Anti-GM1 antibodies can be found in some patients but it is unclear whether these antibodies are pathogenic. Intravenous immunoglobulin is the mainstay of treatment but other immunosuppressive treatments can also be effective.
机译:多灶性运动神经病(MMN)于1988年首次描述为影响多条运动神经的单纯运动神经病。该诊断完全基于展示选择性影响运动轴突的传导阻滞(CB)的电生理学证据,即使通过运动CB部位也可保留感觉轴突。随后,报道了类似的疾病,但在常规神经传导研究中缺乏可证实的CB,关于没有CB的MMN是否与MMN有关仍存在争议。 MMN被认为是与运动神经免疫攻击有关的炎性神经病。传统的假设是原发性病理是节段性脱髓鞘,但是最近的研究提出了原发性轴索病的可能性。在某些患者中可以找到抗GM1抗体,但尚不清楚这些抗体是否具有致病性。静脉免疫球蛋白是治疗的主要手段,但其他免疫抑制治疗也可能有效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号